GLP-1 Agonist Meds: The Medications, Formats, and Uses

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where metabolic science, GLP-1 pathway biology, and the genetics that shape each person’s response are unpacked in plain language. Browse the full Peptides & GLP-1 library.

When people search "glp 1 agonist meds," they are asking about the medications in the GLP-1 receptor agonist family — the actual prescription products rather than the abstract mechanism. This guide keeps the focus on the medicines: what they are, how they reach the body, what they have been approved to do, and the personal biology that underlies any of them.

The "meds" behind the mechanism

Every product in this category shares one job: activating the glucagon-like peptide-1 receptor. Some compounds also engage the GIP receptor, and investigational molecules reach further into glucagon-receptor activity. Different manufacturers make different branded versions, but the receptor-level action is the connective thread across the class.

How the medications are administered

Route matters when you are comparing products. Most GLP-1 receptor agonist medications are given by subcutaneous injection, typically on a weekly or daily schedule depending on the compound. As of April 2026, Rybelsus stands alone as the FDA-approved oral tablet in the group.

What the label allows

Approved uses across these medications fall into two established lanes: type 2 diabetes, which the class has covered since exenatide's 2005 approval, and chronic weight management, opened up by liraglutide (Saxenda) in 2014. Each medication carries its own FDA label spelling out its specific approved indication.

What they cost

There is no single price tag for "GLP-1 agonist meds." Monthly list price shifts with the exact compound and formulation, and April 2026 figures reflect that spread. The number you see quoted always depends on which specific product is being discussed.

Comparing the medications sensibly

When someone searches for the "meds" specifically, they are usually trying to line products up side by side. A few axes make that comparison manageable. The first is route: most are subcutaneous injections, while Rybelsus is the lone oral tablet as of April 2026. The second is schedule — some products are dosed weekly, others daily — which shapes how the medicine fits into daily life. The third is the approved indication, since a product cleared for type 2 diabetes is a different regulatory animal from one cleared for chronic weight management, even when the molecule overlaps.

The fourth axis, and often the most consequential, is coverage. Because insurers frequently tie benefits to a specific brand-and-indication pairing, the exact same molecule can end up costing very different amounts depending on which product is dispensed and why it was prescribed. None of these comparisons should be made in isolation from a clinician, but walking into that appointment already understanding the axes — route, schedule, indication, coverage — makes the conversation more productive and less overwhelming.

There is a related point about generics that trips people up. Because several of these medications share an underlying molecule across different brand names, it is tempting to assume they are freely interchangeable. In practice, each branded product is approved for its own indication, and insurers frequently reimburse based on that exact pairing rather than the molecule alone. A compounded formulation, meanwhile, is a separate category again — not a generic and not identical to any branded product. Keeping these buckets distinct — branded products, their approved indications, and compounded options through licensed pathways — prevents the common mistake of treating chemically similar medicines as though they were automatically the same purchase, at the same price, and under the same coverage rules.

Personal biology beneath the medicine cabinet

Any of these medications acts on a metabolic system shaped by inherited variation. FTO variants affect appetite and fat-mass set-point, GLP1R is the receptor gene the drugs target, and MC4R anchors satiety signaling in the brain. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights to describe that terrain. It is 503A-era educational context — it does not predict how you will respond to any medication.

PlexusDx supplies the class's active ingredient through clinician-supervised, compounded Weight Management Protocols, positioning the genetic report as an upstream, test before you invest companion to the provider conversation.

Frequently Asked Questions

What medications count as GLP-1 receptor agonists?

They are prescription medicines that activate the glucagon-like peptide-1 receptor, made by various manufacturers. Some also engage the GIP receptor. Each is approved for specific uses — type 2 diabetes or chronic weight management — under its own FDA label, so the exact indication is product-by-product.

Are these medications pills or injections?

Most GLP-1 receptor agonist medications are subcutaneous injections dosed weekly or daily by compound. As of April 2026, Rybelsus is the only oral tablet the FDA has approved in the class. Your clinician chooses the format based on the specific approved product.

Why does the price of GLP-1 meds vary so much?

Because "GLP-1 agonist meds" is a class, not one product. Monthly list price moves with the specific compound and formulation as of April 2026. There is no universal figure — the cost you encounter reflects the particular medication and how it is dispensed.

Keep exploring the PlexusDx Education Hub for more grounded, provider-minded answers. Return to the Peptides & GLP-1 library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.